Literature DB >> 7429768

Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.

M D Trousdale, E C Dunkel, A B Nesburn.   

Abstract

Acyclovir, a new potent antiviral drug, was used to treat herpes simplex virus (HSV) infection in the rabbit ocular model. Acyclovir (3% ointment) used topically one to five times a day on acute ocular HSV infection gave beneficial results as measured by a reduction in corneal involvement, conjunctivitis, iritis, and corneal clouding. Topical treatment did not prevent the establishment of latent HSV infection. Intravenous acyclovir used two times a day (50 mg/kg) on rabbits with latent HSV infection appeared to suppress HSV in the nervous system but did not eradicate established latent HSV infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429768

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

Authors:  D Pavan-Langston
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.

Authors:  W G Liu; Z J Chen; J Z Song; Z X Ma
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 3.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Neuritic uptake and transport of antiviral drugs modifying herpes simplex virus infection of rat sensory neurons.

Authors:  B Svennerholm; R Ziegler; E Lycke
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  Quantitation of herpes simplex virus type 1 shed in preocular tear film of rabbits treated with acyclovir.

Authors:  M T Green; E C Dunkel; B L Morris
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Effect of discontinuous acyclovir treatment on in vitro reactivation of herpes simplex virus from latently infected trigeminal ganglia.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

7.  A double-controlled evaluation of acyclovir and vidarabine for the treatment of herpes simplex epithelial keratitis.

Authors:  W R Yeakley; P R Laibson; M A Michelson; J J Arentsen
Journal:  Trans Am Ophthalmol Soc       Date:  1981

8.  Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection.

Authors:  Anthony B Nesburn; Ilham Bettahi; Gargi Dasgupta; Alami Aziz Chentoufi; Xiuli Zhang; Sylvaine You; Naoyuki Morishige; Andrew J Wahlert; Donald J Brown; James V Jester; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Effects of topical applications of phosphonoacetate on colonization of mouse trigeminal ganglia with herpes simplex virus type 1.

Authors:  R J Klein; A E Friedman-Kien; L Kaley; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

10.  Acyclovir treatment in stromal herpetic keratitis.

Authors:  J A Oosterhuis; R van Ganswijk; J Versteeg
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.